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Abstract 
 
 
Rationale: Cardiac tissue cohesion relying on highly ordered cardiomyocytes (CMs) interactions, is 
critical since most cardiomyopathies are associated with tissue remodelling and architecture 
alterations. 
Objective: Eph/ephrin system constitutes a ubiquitous system coordinating cellular communications 
which recently emerged as a major regulator in adult organs. We examined if eph/ephrin could 
participate in cardiac tissue cytoorganization. 
Methods and Results: We reported for the first time the expression of cardiac ephrin-B1 in both 
endothelial cells and CMs. In CMs, ephrin-B1 displayed specific localization at the lateral membrane. 
Ephrin-B1 knock-out (KO) mice progressively developed cardiac tissue disorganization with loss of 
adult CM rod-shape and sarcomeric and intercalated disk structural disorganization confirmed in CM-
specific ephrin-B1 KO mice (cKO). CMs lateral membrane exhibited abnormal structure and 
increased stiffness as shown by electronic and atomic force microscopy. In wild-type CMs, ephrin-B1 
interacted with claudin-5/ZO-1 complex at the lateral membrane while the complex disappeared in 
KO/cKO mice. Ephrin-B1 deficiency resulted in decreased mRNA expression of CM basement 
membrane components and disorganized fibrillar collagen matrix, independently of classical 
integrin/dystroglycan system. KO/cKO mice exhibited increased left ventricle diameter and delayed 
atrioventricular conduction. Under pressure overload stress, KO mice were prone to death and 
exhibited striking tissue disorganization correlating with heart failure. Finally, failing CMs displayed 
downregulated ephrin-B1/claudin-5 gene expression linearly related to the ejection fraction. 
Conclusions: Ephrin-B1 is necessary for cardiac tissue architecture cohesion by stabilizing the adult 
CM morphology through regulation of its lateral membrane. Since decreased ephrin-B1 associated 
with molecular/functional cardiac defects, it could represent a new actor in the transition toward 
heart failure. 
 
 
 
 
 
Key Words: cardiomyocyte – extracellular matrix – lateral membrane – cardiac tissue architecture – 
heart failure 
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Non standard Abbreviations and Acronyms 
 
AFM Atomic Force Microscopy 
CM Cardiomyocyte 
EC Endothelial Cell 
ECM Extracellular matrix 
HF Heart failure 
I-B4 Isolectine-B4 
ID Intercalated Disk 
KO Knock-out 
WGA Wheat Germ Agglutinin 
WT Wild-Type 
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Introduction  
 
 The heart constitutes a particular compact organ relying on strong tissue architecture cohesion 
and tight cellular interactions that ensure both mechanical and electrochemical coupling. Thus, most 
cardiopathies are associated with cardiac tissue remodelling and with alterations in architecture 
involved in disease progression toward heart failure (HF). Despite considerable advances in the field 
and development of effective drugs, HF still remains a prevalent condition associated with high 
morbidity and mortality rates. This could be in part explained by still imperfect knowledge of 
molecular basis at the origin of HF. In fact, to date, most research has focused on cardiomyocyte 
(CM) contractile dysfunction but has essentially ignored the importance of modifications in CM 
interactions with their environment in the cardiac tissue. Thus, a thorough analysis of CM interactions 
involved in the stability of cardiac tissue architecture may help in the identification of new potential 
therapeutic targets for prevention and treatment of cardiac remodelling leading to heart failure.  
 Functional adult CMs are organized within the tissue through both cell-cell interactions 
involving end-to-end contacts via the intercalated disk (ID) and cell-matrix interactions through 
receptors localized along the sarcolemma. Together, these structures control connections of contractile 
myofilaments to the plasma membrane of the CM and have garnered attention due to their 
involvement in cardiac diseases 1, 2. Despite numerous junctions present at the ID have been well 
characterized 3, little is known regarding the molecular nature of lateral membrane components. To 
date, only integrin and sarcoglycan systems specifically connecting contractile apparatus of the CM to 
the extracellular matrix (ECM) have been described 4, 5.  
Eph receptor tyrosine kinases and their membrane-bound ligands ephrins form an essential 
intercellular communication system associated with cytoskeleton regulations 6. In the last few years, 
the role of Eph/ephrin system has been extensively investigated mainly in developing tissues, 
including the central nervous and vascular system. Eph/ephrins have been implicated in various 
processes including neuronal network formation, guidance of migrating cells, axonal pathfinding but 
also in the regulation of angiogenesis 7, 8. More recently, Eph/ephrins have been shown to be major 
actors in the pathophysiology of cancer 9. So far, little is known regarding their putative roles in adult 
tissue but they have been reported to participate in modulation of bone remodelling 10 and insulin 
secretion 11. Finally, their role in the control of cell-cell interactions has been underlined in kidney 12 
and crystalline lens 13 emphasizing the importance of ephrin system in maintaining tissue architecture.  
A role for EphA3 receptor has been identified in heart development and morphogenesis at the 
embryonic stage 14. However, the Eph/ephrin system has never been explored in adult cardiac tissue. 
In fact, mutations in the ephrin-B1 gene in humans have been associated with Cranio Frontonasal 
Syndrome which is characterized by craniofacial dysmorphies with some of the mutations associated 
also with cardiomyopathy 15. Moreover, several studies have reported specific ephrin-B1 regulation of 
cellular junctions such as gap junctions 16, tight junctions 17 and also ECM receptors 18, 19. All of these 
junctions are important regulators for cell and tissue cohesion and are altered in different models of 
cardiomyopathy. Thus, we decided to explore the potential cardiac role of ephrin-B1. 
 In the present study, using an ephrin-B1 knockout (KO) mouse model (efnb1-/-), we identified 
ephrin-B1 as a new structural protein specific for the lateral membrane of the CM involved in adult 
cardiac tissue architecture stabilization. Using a wide array of approaches from light and electron 
microscopy, nanomechanical and biochemical measurements to in vivo functional assays, we show 
that the lack of ephrin-B1 leads to cardiac tissue alterations that may predispose to pathological 
responses under cardiac stress. 
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Methods 
 
An expanded methods section is available in the Online Data Supplement. 
 
Statistical analysis. All data represent the mean ± S.E.M. of 3 to 10 independent experiments as 
indicated. Statistical significance of the data was assessed using unpaired 2-tailed Student’s t test (*P 
< 0.05, **P < 0.01, ***P < 0.001, ns, non significant). In some cases, Chi square test was used instead 
(Kaplan-Meier curves). 
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Results  
 
Ephrin-B1 is largely expressed in cardiac muscle and is specific of the endothelial cell and the 
lateral membrane of the mature adult cardiomyocyte 
We first assessed the expression of ephrin-B1 in adult heart from wild-type (WT) mice. Western-blot 
analysis revealed abundant and specific expression of ephrin-B1 in whole cardiac tissue extracts 
(Figure 1A). Fluorescence imaging of heart cryosections revealed that ephrin-B1 was expressed in all 
heart compartments (left and right ventricles, septum) (not shown). Cell membrane Wheat Germ 
Agglutinin (WGA) co-staining showed that the protein was specifically expressed at the lateral 
membrane of cardiomyocytes (CMs) with no expression in the intercalated disk (ID) (Figure 1 B-C).. 
Similar pattern of ephrin-B1 expression was obtained in CMs from adult rat cardiac tissue (Online 
Figure I, A). Beside CM staining, ephrin-B1 was also detected in endothelial cells (ECs) from both 
micro- and macrovasculature as demonstrated by co-localization with isolectin-B4 (I-B4), a specific 
EC marker (Figure 1 B-C). Both CMs and ECs staining were completely lost in KO mice 
demonstrating the specificity for ephrin-B1 cardiac expression and localization (Figure 1B). 
Compartmentalizations of ephrin-B1 at both lateral membrane of CMs and ECs were further 
confirmed by immunogold electron microscopy (Figure 1D). Interestingly, ephrin-B1 localization in 
the CM was regulated during postnatal myocardial maturation period (3 weeks). Indeed, ephrin-B1 
was totally absent from the lateral membrane of the CM the first postnatal days when it was only 
expressed in the nucleus (Online Figure I, A), while its expression at the lateral membrane correlated 
with the final adult CM maturation step, most likely indicating a specific role of this protein after birth 
in the lateral membrane of the mature CM. By opposition, ephrin-B1 expression/localization in adult 
ECs was already detected in ECs immediately after birth (Online Figure IB). 
 
Ephrin-B1 knockdown disrupts cardiac tissue architecture cohesion and cardiomyocyte 
morphology 
To understand the role of ephrin-B1 in the mature CM, we analyzed the cardiac phenotype of the 
general ephrin-B1 KO mice which were previously described 20. We first undertook a histological 
analysis using H&E staining of cardiac tissue from WT and KO mice at different development stages 
(3 weeks and 2 months). Three weeks after birth, there was no evidence for cardiac tissue 
modification in KO mice compared with WT (Figure 2A, upper). However, at 2 months of age, in 
contrast to WT hearts characterized by a tight and strong cohesion between CMs, disorganization of 
CMs with a “wavy” aspect could be visualized randomly in all heart compartments (septum, right and 
left ventricle) from KO mice (Figure 2A, middle) with some CMs exhibiting whorled appearance 
(Figure 2A, lower). These changes were detected in all KO mice, but present focal distribution within 
the tissue. Thus, ephrin-B1 KO mice developed progressive alteration of the cardiac tissue 
architecture which correlated with the timing of ephrin-B1 lateral membrane expression in the mature 
adult CM from WT animals. Morphometric analysis of cell membranes by WGA-staining further 
confirmed modification of CMs morphology that lost their hallmark rod-shape (Figure 2B). 
Quantification studies demonstrated significant decrease in cross-sectional area of CMs from KO 
mice in fixated cardiac tissue (Figure 2C) with no difference in cell density (WT: 10.6 ±0.7 CMs per 
mm2; KO: 11.3 ± 1.1 CMs cells per mm2). In agreement with tissue observations, isolated adult KO 
CMs displayed a significant reduced short axis while increasing their long axis compared with WT 
(Figure 2D). Even though KO mice displayed CMs morphology abnormalities, this was not correlated 
with development of cardiac fibrosis (Online Figure II, A). Aberrant cell differentiation during heart 
development could not account for morphological CM changes in KO mice, since all 3 weeks-old 
mice exhibited mature rod-shape CMs and tissue alterations were evident only 2 months after birth. 
Moreover, KO animals did not exhibit cardiac development abnormalities precluding a major role for 
ephrin-B1 in cardiogenesis. It is noteworthy that despite broad expression of ephrin-B1 in the cardiac 
capillary network, 2-months old KO mice showed no changes in capillary density as quantified by 
Isolectin-B4 ECs-staining (Online Figure II, B) nor evidence for myocardial necrosis or inflammation 
as visualized on H&E staining, thus demonstrating integrity and functionality of the cardiac 
vasculature. Altogether, these results supported a role for ephrin-B1 in the maintenance of adult 
cardiac tissue architecture essentially by controlling CMs morphology. 
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Ephrin-B1 regulates the cardiomyocyte lateral membrane structure and nanomechanical 
properties through stabilization of claudin-5 
Given the specific expression of ephrin-B1 at the lateral membrane of the CM, we questioned whether 
disturbance of the lateral membrane accounted for the abnormal CM morphology in KO mice. 
Electron microscopy revealed significant structural alterations of the lateral junction characterized by 
an abnormal non linear appearance compared with WT mice (Figure 3A).  To rule out contribution of 
other cardiac cell types in the CM phenotype, we generated a cardiomyocyte-specific ephrin-B1 KO 
mice (cKO) (Online Figure III). In cKO mice, we confirmed lateral membrane disorganization of the 
CM (Online Figure IV, A). In correlation with the alteration of the CM lateral membrane structure, 
atomic force microscopy (AFM) study revealed a significant 3 fold increase of Young Modulus 
(Elasticty) in CMs from KO mice ranging from 35.5 ± 6.4 kPa to 62.4 ± 13.1 kPa compared with 12.5 
± 1.3 kPa to 21.3 ±3.6 kPa in WT mice (Figure 3B, lower panel), thus indicating that the lack of 
ephrin-B1 in the CM increased the stiffness of the lateral membrane. It must be noticed that the 
repartition of Young Modulus was very homogeneous throughout the lateral membrane of WT CMs, 
while it showed high heterogeneity in KO CMs as represented by the larger distribution of young 
modulus frequency (Figure 3B, right panels), most probably reflecting different levels of morphology 
modifications at the lateral membrane surface.  
To understand the molecular basis accounting for this phenotype and given the interaction of 
the lateral membrane of the CM with the extracellular matrix, CM-matrix interactions predominantly 
regulated by integrin- and dystroglycan-based complexes were first analyzed. We found that 
localization (Online Figure V, A) and expression (Online Figure V, B) of both β1-integrin and β-
sarcoglycan/α-dystroglycan (glycosylation) complex along the plasma membrane were unchanged in 
hearts from KO mice compared to WT as shown by immunofluorescence and immunoblot staining 
respectively, thus demonstrating regular and functional CM-matrix junction complexes in the absence 
of ephrin-B1. We looked then at the tight junction transmembrane protein claudin-5, a specific 
endothelial cell tight junction component, which was previously localized at the lateral membrane of 
the CM and whose downregulation correlated with similar modification of lateral membrane structure 
in mice models of cardiomyopathy to that observed in ephrin-B1 KO mice 21. We confirmed the 
presence of claudin-5 in the microcirculation and along the lateral membrane of CMs in control hearts 
(Figure 3C; Online Figure IV, B) and did not detect any labelling in the ID. Specific expression of 
claudin-5 at the lateral membrane of the CM was more readily detectable in rat heart (Online Figure 
V, C). By contrast, claudin-5 was completely absent from the lateral membrane in both general and 
conditional ephrin-B1 KO mice (Figure 3C and Online Figure IV, B) and showed specific 
downregulation as revealed by the significant decrease in protein (Figure 3D), and gene expression 
level (Figure 3E), thus suggesting specific regulation of claudin-5 by ephrin-B1. Similarly, the 
intracellular scaffolding claudin-associated-protein ZO-1, which was detected at both lateral 
membrane and ID in CMs from control hearts (Figure 3C, left panel and Online Figure IV, C), 
disappeared from the lateral junction in KO and cKO  mice (Figure 3C and Online Figure IV, C). 
However, ZO-1 further accumulated in the ID as evidence by the significant increase in ZO-1 
fluorescent staining (Figure 3C, WT: 112.0 ± 6.2 fluorescence/pixel², KO: 138.3 ± 8.2 
fluorescence/pixel², means ± SEM, P<0.05). Relocalization of ZO-1 was further supported by the lack 
of modification of ZO-1 protein (Figure 3D) and gene expression (Figure 3E). Altogether, these 
results supported a role for ephrin-B1 in the stabilization of claudin-5/ZO-1 junctional complex at the 
lateral membrane of the CM. The regulation of claudin-5 by ephrin-B1 at the lateral membrane most 
likely relates to a direct mechanism since both claudin-5 and its ZO-1 partner were found associated 
with ephrin-B1 in isolated CMs as shown by co-immunoprecipitation (Figure 3F) and claudin-5 could 
directly interact with ephrin-B1 in BRET experiments (Figure 3G). Specific destabilization of 
claudin-5/ZO-1 complex in ephrin-B1 KO mice most likely preceded and initiated the lateral 
membrane disorganization of the CM. Indeed, lack of claudin-5 at the lateral membrane was evident 
in all CMs from 2 month-old KO mice while modification of their lateral membrane structure was 
only focal at same age. It follows that ephrin-B1 may regulate the morphology of the CM by 
controlling lateral membrane structure through a mechanism involving the specific adhesion protein 
claudin-5. 
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Ephrin-B1 knockdown impairs basement membrane of the cardiomyocyte and fibrillar 
collagens organization  
Because CMs are anchored to the extracellular matrix (ECM) through their lateral membrane and 
ephrin-B1 KO mice exhibited structural alteration of the lateral membrane, we examined the 
morphology of cardiac ECM from KO and WT mice by electron microscopy. In contrast to the well-
organized pattern in WT, the basement membrane and the fibrillar collagen bundles were highly 
disorganized in the KO mice (Figure 4A) as well in cKO mice (Online Figure IV, D), most likely 
indicating destabilization of the overall ECM structure. Interstitial space separating two adjacent CMs 
was irregular in all ephrin-B1 KO/cKO mice (Figure 4A, Online Figure IV, D). These modifications 
correlated well with those of the lateral membrane as they are detectable only in CMs showing high 
levels of lateral membrane defects. Abnormalities of the ECM structure observed in KO mice most 
likely related to an impairment of expression of all ECM components/regulators by the CM since their 
expression levels were all dramatically reduced as measured by quantitative qPCR (Figure 4B). 
However, the reduced expression of interstitial fibrillar collagens and degradation ECM system by the 
CM did not impact their expression in the whole cardiac tissue (Online Figure VI). This most 
probably related to the contribution of the other cardiac cells in the synthesis of the ECM components. 
In agreement with these observations, we didn’t notice any modifications of cardiac collagen I and III 
levels between WT and KO mice as previously indicated (Online Figure II, A). By contrast, basement 
membrane components of the CM are specific for the myocyte cell only. Given the importance of the 
basement membrane in controlling cell morphology, these results suggest that ephrin-B1 maintains 
lateral membrane morphology of the adult CM by a new mechanism involving regulation of its 
interaction with the basement membrane. This specific CM-matrix interaction underlies a novel role 
in the stabilization and organization of the cardiac ECM. 
 
Ephrin-B1 knockdown results in abnormal intercalated disk and sarcomeric structure  
Because lateral membrane of the CM is directly connected at both end to the ID which anchors 
myofilaments, we next examined whether modifications of the lateral membrane in these mice 
impacted on the different cell-cell junctions of the ID and the sarcomeric apparatus. In opposition to 
WT mice characterized by ID-components from adherent junction (N-cadherin), desmosomes 
(desmoplakin 1/2) and gap junctions (connexin-43) regularly organized along the ID (Figure 5A), 
these proteins demonstrated a significant spatial disorganization of all in the KO mice showing 
irregular spread dots labelling along a wider ID with no modification of their expression levels 
(Online Figure VII, A-C). These modifications most likely emanated from ultrastructural alterations 
of the ID as shown by the higher degree of circumvolution of the ID in electron micrographs from KO 
hearts (Figure 5B). Beside abnormal ID structure, there was not clear abnormality in the ID space 
between CMs from WT and KO mice (Online Figure VII, D) nor apparent disorganization in the 
electron-dense structures associated with the ID or in the myofilaments attachments at these locations. 
Generally, alteration of proteins directly participating in ID structure influences expression of other 
ID components 22. Thus, modification of ID morphology without any modulation of associated-
junctional components most likely indicates an indirect consequence of ephrin-B1 deletion linked to 
the lateral membrane destructuration. 
Ephrin-B1 deficient CMs displayed misalignment of both their myofibrils as indicated by rhodamine-
phalloïdin staining (Figure 5C) despite no change in the total amount of β-actin (Figure 5D). In 
correlation with myofibrils structure defects, α-actinin staining also revealed Z-lines misalignment 
(Figure 5C) associated with significant loss of α-actinin expression (Figure 5D). These changes were 
detected in all 2 month-old KO mice but still exhibited focal localization within the heart tissue most 
likely reflecting an indirect consequence of ephrin-B1 deletion at the lateral membrane. Similar Z-
lines misalignment was reported in mice models with deletion of intermediate filament (IF) desmin or 
desmin-associated proteins 23, 24. However ephrin-B1 KO phenotype is unlikely to be related to desmin 
deregulation since desmin expression and attachment to Z-lines was preserved (Online Figure VIII, A 
and B). Finally, despite structural changes in the myofilaments in KO mice, we did not observe any 
modification of microtubule networks as indicated by similar expression and distribution of tubulin in 
CMs from WT and KO mice (Online Figure VIII, C and D). Electron microscopy confirmed structural 
sarcomeric disorganization that could account for disruption of myofibrillar organization (Figure 5E). 
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Indeed, KO mice exhibited high heterogeneity of their sarcomeres morphology (Online Figure VIII, 
E-G) together with a lack of actin-enriched I-bands in all sarcomeres (Figure 5E) despite no 
modification of total actin expression (Figure 5D), most likely indicated relaxed aspect of the 
sarcomere. Similar ultrastructural abnormalities of sarcomeric apparatus have been observed in the 
cKO mice (Online Figure IV, E). Again, modification of sarcomeric structure of CMs from KO mice 
without major modification of its integrity more probably related to indirect consequences of the 
deletion of ephrin-B1 rather than a direct role of this protein in the contractile apparatus per se.  
 
Ephrin-B1 knockdown results in left ventricle chamber dilation and cardiac electrical 
conduction impairment 
To test whether ephrin-B1 played a role in cardiac physiology, we analyzed the cardiac phenotype of 
efnb1-/- mice. At 2 months of age, ephrin-B1 deficient mice (KO, cKO) displayed no difference in 
heart-to-body weight ratio compared with respective controls (Table 1, upper). Interestingly, 
echocardiography analysis revealed significant intraventricular dilation in ephrin-B1 KO mice as 
shown by significant enlargement of the left ventricle at end diastole (LVEDD) with no change in left 
ventricular wall dimensions (DPWT) or gross alterations in systolic contractile performance compared 
with WT (Table 1, middle). Enlargement of LVEDD was confirmed in cKO mice but with further 
significant decrease of IVSTd and DPWT  (Table 1, middle). Beside cardiac morphology and 
contractile function, electric properties of the heart were investigated by electrocardiography. 
Although depolarization and repolarization of the KO ventricle were normal (QRS complex and QT 
interval), both efnb1 KO and cKO mice exhibited significant bradycardia associated with a decrease 
of the atrioventricular conduction as evidenced by a prolonged PR interval compared with WT mice 
(Table 1, lower). Taken together, these data indicated that the specific absence of ephrin-B1 in the 
CM promoted defects in both heart morphology and conduction. 
 
Ephrin-B1 knockdown confers mice hypersensitivity to pressure overload 
Given high modifications of cardiac tissue cohesion detected in efnb1-/- mice, we assessed its adaptive 
response to biomechanical stress imposed to the left ventricle under conditions of high blood pressure 
after ascending aortic banding (AAB) as previously described 25. Remarkably, 59 % of the ephrin-B1 
KO mice died 24 hrs following AAB, compared with no death in the WT group (Figure 6A). While 
we are uncertain why ephrin-B1 KO mice perished, banded mice that survived developed significant 
higher hypertrophy response compared with WT after 30 days of AAB as indicated by higher 
variation of cross-sectional area of myocytes from KO banded (Figure 6 B) and higher variations in 
interventricular septum (IVST) or LV posterior wall thickness (DPWT) (Online Figure IX, A, Online 
Table 1 through 3) measured before and after AAB. Interestingly, we measured similar fetal 
reprogramming and development of reparative fibrosis in KO and WT mice (Online Figure IX, B and 
C), most likely indicating that the increased hypertrophy detected in KO mice was more related to the 
morphological defect of the CMs only and not to an increased gene-related compensatory response. 
This is further supported by the lack of differences in HW/BW ratio between KO and WT mice after 
AAB. Interestingly, although systolic function was not significantly different 30 days after AAB 
between WT and KO mice, high EF variability was noticed exclusively in KO, with some animals 
showing high EF reduction (Figure 6C) correlating with LVEDD dilatation (Figure 6D), thus 
indicating that ephrin-B1 deletion predisposed to failure. More striking feature of cardiac tissue from 
KO banded animals came from histomorphologic analysis that revealed fundamental tissue disarray 
with loss of CM integrity that reminisces that of human patient with end-stage HF (REF Book 
chapter).Myocytes intersect at various angle and showed whorled appearance, thus indicating a lack 
of CMs stability within the tissue (Figure 6E, H&E). Modifications in interstitial collagens I and III 
could not account for the instability of CMs since their gene expression levels were similar in both 
WT and KO cardiac tissue (Online Figure IX, D). Myofibrils can be seen running in different 
directions (Figure 6E, H&E, left-middle). Cardiac tissue demonstrated signs of CMs necrosis 
characterized by cellular swelling, disruption of myofibrils, loss of nuclei and cytoplasmic details and 
inflammatory cells in close contact to cell debris (Figure 6E, H&E, right). Modifications of CMs were 
largely evident on WGA-heart sections staining (Figure 6E, WGA). Phenotypic changes of cardiac 
tissue from KO banded mice also included high dilatation and disorganization of the vessels from the 
microcirculation which were crossing and interrupting orientation of CMs in the myocardium (Figure 
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6E, I-B4) despite no change in the capillary network density (Online Figure IX, E). We found high 
heterogeneity of these features in all KO mice. Interestingly, morphologic cardiac tissue 
disorganization correlated perfectly with loss of cardiac performance since KO banded mice 
demonstrating worst shortening fraction exhibited the more dramatic cardiac tissue architecture 
disarray. In correlation with a putative role of ephrin-B1 in transition toward heart failure, we found 
that encoding genes for ephrin-B1 and its cognate claudin-5 partner were significantly reduced in 
CMs from a mouse model of TAC-induced heart failure (Figure 6F) and that ephrin-B1 gene 
expression positively correlated with EF (Figure 6G). Thus, cardiac expression of ephrin-B1 appears 
to be crucial for cardioprotective response to severe pressure overload by preserving overall cohesion 
of cardiac architecture. Altogether, these results highlighted the importance of ephrin-B1 in the 
adaptative response to pressure overload and suggest its potential role in the transition toward cardiac 
failure. 
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Discussion  
 
In this study, we identify ephrin-B1 as a novel component of the lateral membrane of the adult CM. 
General loss of ephrin-B1 leads to a progressive disorganization of cardiac tissue architecture 
associated with adult CM morphology defects directly related to the absence of ephrin-B1 at CM the 
lateral membrane as demonstrated in the conditional cardiomyocyte-specific ephrin-B1 KO mouse 
model. Ephrin-B1 controls CM morphology through stabilization of the lateral membrane by a novel 
mechanism most likely involving its interaction with the ECM independently of the 
mechanotransduction systems. Cardiac architecture abnormalities are associated with an increased left 
ventricle diameter and delayed atrio-ventricular conduction. Finally, although the absence of ephrin-
B1 did not modify compensatory adaptation to pressure overload stress, it precipitates cardiac tissue 
disorganization classically observed in human HF. These data clearly indicate that ephrin-B1 is an 
important regulator cardiac tissue architecture that could be involved in cardiac pathologies.  
 
Ephrin-B1 deficiency leads to specific morphological and molecular modification of the 
lateral membrane of the CM associated with subsequent modifications of the intercalated disk and 
sarcomeric apparatus structure and loss of ECM integrity. We propose a model whereby ephrin-B1 
stabilizes rod-shape adult CM morphology by regulating specific interactions between the lateral 
membrane and the ECM and thus the tension force distribution at the cell surface (Figure 7). 
Accordingly, in the absence of ephrin-B1, the CM shrinks and lengthens as a consequence of lateral 
membrane destabilization thus increasing membrane stiffness as demonstrated by AFM studies. In 
WT mice, the lateral tension generated by the cell-matrix interaction within the CM could play an 
indirect role in stretching both sarcomeric apparatus and the ID (Figure 7). To date, only ECM 
receptors localized all along the sarcolemma of the CM acting were identified as direct lateral tensors 
for sarcomeres 1, 26-28. Thus, the lack of ephrin-B1 induces detachment of the lateral membrane from 
the ECM and as a consequence compresses the ID. As a consequence of ID compaction and because 
ID structure is known to anchor and stretch myofibrils, CMs exhibit myofibrils misalignment, 
irregular sarcomere size and loss of visible actin thin strand I-band. Similar modifications have been 
observed in transgenic mouse models with modifications of ID structure22. Finally, misalignment of 
Z-lines in CMs from efnb1-/- mice despite the lack of modification in desmin filaments also most 
likely related to the loss of lateral tension at the cell membrane. Thus, the decrease of CM width may 
probably indirectly relax the desmin network attached to the lateral membrane thus mimicking CM 
features observed in the absence of desmin 23, 24. 
 
Previous studies have already suggested a role for ephrin-B1 in the maintenance of 
cytomorphology of epithelial cells in the adult kidney 12 as well as for other members from eph/ephrin 
family in different tissues 13, 14. However, our data provide first evidence for its importance in 
stabilization of cardiac tissue architecture independently of cell-cell interaction given the absence of 
CMs connection through the lateral membrane where it is specifically expressed. Several studies have 
proposed a role for ephrin-B1 independently of its trans interaction with its cognate Eph receptor 29, 
for instance by directly interacting in cis with claudin proteins core component of the tight junction. 
Similarly, ephrin-B1 was found to directly interact with claudin-5 in adult CMs to stabilize its 
localization at the lateral membrane. Unexpectedly, the presence of claudin-5 in the absence of tight 
junctions at the lateral membrane suggests a new role for claudin-5. The unusual presence of claudin 
proteins in non junctional cell membranes was already reported with some isoforms interacting with 
unrelated transmembrane receptor 30, 31. However, the functional significance of claudin proteins apart 
from the intercellular tight junction is currently unknown. Similar observations have already been 
described for gap junction core components connexins, another class of adhesion molecule, outside 
the gap junction, where they exhibit new function 32. The fact that the ephrin-B1/claudin-5 complex 
was localized all along the plasma membrane could argue for its specific role in directly connecting 
lateral membrane of the CM to the ECM. However, whether ephrin-B1 or claudin-5 could act as a 
direct receptor for ECM components has never been shown. Nevertheless, our observations argue for 
a new role for ephrin-B1 in stabilization of claudin adhesion molecules at the plasma membrane 
independently of tight junctions.  
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 Ephrin-B1 expression at the lateral membrane of the CM occurs only following the first 
postnatal days and only during the CM terminal differentiation process (postnatal days 1 to 20) when 
it acquires its characteristic rod-shape morphology. Because the lateral membrane of the adult CM is 
required for maintenance of its characteristic rod-like shape, its modification in the ephrin-B1 KO 
mice could alter the paving shape of the CM as readily observed. Nevertheless, if ephrin-B1 actively 
participates in the establishment of the lateral membrane and thus the adult CM morphology, one 
would have expected that in its absence, CMs would never achieve their characteristic rod shape. This 
is however unlikely since CMs still achieve their mature rod shape in KO mice as evidenced in 3 
weeks-old animals and show progressive morphological transformation only after 2 months of age, 
thus highlighting a role for ephrin-B1 independently of CM maturation initiation process. Therefore, 
ephrin-B1 more likely plays a role in stabilizing the lateral membrane of the CM subsequently to 
lateral membrane set up. In line with this assumption, alteration of the adult CMs morphology in the 
absence of ephrin-B1 appears progressively only after 2 months of age correlating with ephrin-B1 late 
timing set up at the lateral membrane of the adult CM. Thus, adult CMs morphology defects detected 
in ephrin-B1 KO mice strikingly referred to the role of ephrin-B1 at the lateral membrane of the 
mature CM. 
 
 Our study highlights a new mechanism involved in CM-ECM interaction specific to the 
lateral membrane but independent from the classical integrin and dystroglycan systems establishing 
physical connections between the ECM and the intracellular contractile machinery. Accordingly, mice 
exhibiting defects in one of these two systems clearly demonstrate specific cardiac contractility 
defects 33-36. By opposition and in agreement with integrin or dystroglycan independent pathways, 
contractile function was preserved in ephrin-B1 KO mice, thus correlating with the lack of dramatic 
changes in sarcomeric apparatus core components. Moreover, integrity/functionality of the integrin 
system in ephrin-B1 KO mice is further supported by the expected classical adaptation to pressure 
overload known to be directly sensed by integrins. Finally, the lack of integrin or dystroglycan 
components did not lead to structural abnormalities of the lateral membrane as observed in ephrin-B1 
KO mice.  
 
 Also, it appears that this specific CM lateral membrane-ECM interaction supports a new 
structural role for the cardiac tissue architecture in maintaining overall integrity of both CMs and the 
ECM. Similar pattern of ECM disorganization has been already described in hearts from mice lacking 
collagen XV expression which connects basement membrane of the CM to the fibrillar matrix 37. The 
fact that efnb1-/- mice exhibited considerable donwregulation of all the components of the basement 
membrane of the CM most probably arised from a consequence of the disruption of lateral 
membrane/ECM interaction rather than a direct role on basement membrane synthesis per se. In 
agreement with this hypothesis, 3 weeks old-KO mice show preserved rod-shaped polarized CMs, 
thus demonstrating the integrity of matrix synthesis at this stage. Similar feedback regulation on 
laminin synthesis has been already described after disruption of integrin-ECM interaction 38. Because 
cellular basement membrane dictates cell morphology, the progressive defects in basement membrane 
production in ephrin-B1-deficient CMs most probably droved the progressive modification of their 
rod-shape. The lack of basement membrane components could explain the CMs slippage and thus the 
tissue architecture disorganization observed following biomechanical stress. Finally, disruption of 
CM-ECM integrity at the lateral membrane leading to a general lack of cardiac tissue cohesion could 
account for the increase of the left ventricle diameter measured in KO mice.  
 
One striking feature of efnb1-/- mice is their high susceptibility to dazzling death following 
pressure overload despite higher hypertrophic response, thus suggesting some sort of inadaptation. 
Although we are not able to determine the exact defect, the observation that KO mice exhibit a 
delayed atrioventricular conduction together with the morphologic modification of the intercalated 
disk in CMs with abnormal distribution of connexin 43 could indicate increased arrythmogenic 
susceptibility in these mice following pressure overload stress. In line with this assumption, recent 
study showed the importance of heterogeneous connexin 43 distribution in the development of 
ventricular arrhythmias 39. The observation that efnb1-/- mice exhibit high heterogeneous responses to 
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pressure overload is also quite intriguing. However, this could be easily explained by the fact that 
these mice exhibited only focal disorganization of the cardiac tissue at 2 months of age. This is further 
supported by the histological examination of cardiac tissue from banded KO mice which showed high 
variations in the degree of cardiac tissue disarray, even if all mice presented these modifications while 
they were absent in WT mice. Finally, we cannot exclude that disorganization of cardiac vessels 
detected in KO banded mice is also a contributing factor to death. Further studies using targeted 
ephrin-B1 deletion will be necessary to explore this hypothesis. 
 
Of interest, our study provided evidence that lack of ephrin-B1 at the CM lateral membrane 
clearly influences the morphology of the adult CM and its elastic properties. It follows that ephrin-B1 
most probably enforces a physical constraint to stabilize the lateral membrane and, in its absence, the 
CM is more susceptible to external/internal pressures which will directly impact on the CM 
morphology. This is perfectly illustrated by morphological changes observed in KO and cKO mice 
exhibiting ventricle dilatation without any modifications of HW/BW, nor reduction in CMs numbers 
or interstitial ECM. Similarly, this could explain peculiar adaptation of the KO mice during aortic 
banding with exacerbated increase of CMs area while fetal gene reprogramming and changes in 
HW/BW are similar to those observed in WT mice. 
 
The exacerbated hypertrophic morphology of the CMs correlating with high tendency to HF 
in KO banded mice with similar fetal reprogramming and fibrotic compensatory response compared 
with WT mice, suggests that the intrinsic physical properties of the CM lateral membrane can 
influence by itself the progression of pathological hypertrophy toward HF independently of the 
classical hypertrophic reprogramming. In line with this hypothesis, phenotype of banded cardiac 
tissue from efnb1-/- mice reminisces that of human end-stage HF exhibiting high tissue disorganization 
and loss of CM integrity. Moreover, ephrin-B1 and claudin-5 gene expression were considerably 
downregulated in CMs from HF mice model. Similar lack of claudin-5 expression was already 
reported in end-stage HF patients 40. Finally, EF in mice is directly correlated to the level of ephrin-B1 
geen expression. 
 
 In summary, we described a previously uncharacterized specific component of the CM lateral 
membrane, ephrin-B1, which acts as a stabilizer of the CM morphology and the overall cardiac tissue 
cohesion. Interestingly, ephrin-B1 interacts specifically with claudin-5 which was found to be 
downregulated in dystrophic mice models or in human end-stage cardiomyopathy 21, 40. Given our 
results showing interactions between ephrin-B1 and claudin-5, one might expect similar dysregulation 
of ephrin-B1 in human cardiomyopathies. In line with this hypothesis, mouse model of DCM 
associated with claudin-5 downregulation demonstrated similar structural alterations of the lateral 
membrane as seen in the ephrin-B1 KO mice 21. Moreover, efnb1 gene is subjected to large number of 
mutations in patients with craniofrontonasal syndrome with some patients exhibiting cardiopathy 15. 
However, since the role of ephrin-B1 at the adult stage is still new, no study correlating human efnb1 
mutations and the development of cardiomyopathies have been yet performed. To date, HF candidate 
genes concentrated on proteins involved in regulation/composition of CM contractile apparatus. Our 
KO model is characterized by an unusual disorganization of the overall cardiac contractile apparatus 
without classical features observed in models of contractile dysfunction (i.e loss of contractile 
components, calcium pathway contractile regulators…). Lack of contractile dysfunction in young KO 
mice suggest the need for future studies in older animal to clarify whether ephrin-B1 is involved in the 
pathogenesis of cardiomyopathy.  
 We propose that ephrin-B1, and more generally, structural components of the CM lateral 
membrane, could directly be involved in occurrence of HF, thus suggesting a novel pathway which 
needs to be explored beside the classical hypertophic/ fibrotic one. 
 
 
 
 14
Acknowledgements 
We thank Dr. T. Hébert, J.L. Samuel and B. Swynghedauw for critical reading of the manuscript; Dr 
R. D’Angelo, JJ Maoret and Childerick Severac for advice and technical assistance regarding imaging 
(Cellular Imaging Facility IFR150, Rangueil, TRI Platform), qPCR (IFR150-BMT, Quantitative 
Transcriptomic Platform) and Atomic Force microscopy experiments (Bionanotechnologies platform, 
Institut des technologies Avancées en sciences du Vivant (ITAV) UMS 3039) respectively. 
 
 
 
Sources of funding 
This work was supported by BQR grant from Toulouse III Paul Sabatier University (France). 
 
 
 
Disclosures 
None 
 15
References 
 
1. Brancaccio M, Hirsch E, Notte A, Selvetella G, Lembo G, Tarone G. Integrin 
signalling: the tug-of-war in heart hypertrophy. Cardiovasc Res. 2006;70:422-433. 
2. Li J, Patel VV, Radice GL. Dysregulation of cell adhesion proteins and cardiac 
arrhythmogenesis. Clin Med Res. 2006;4:42-52. 
3. Noorman M, van der Heyden MA, van Veen TA, Cox MG, Hauer RN, de Bakker JM, 
van Rijen HV. Cardiac cell-cell junctions in health and disease: Electrical versus 
mechanical coupling. J Mol Cell Cardiol. 2009;47:23-31. 
4. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: 
signaling strength and integrity for the sarcolemma. Circ Res. 2004;94:1023-1031. 
5. Samarel AM. Costameres, focal adhesions, and cardiomyocyte mechanotransduction. 
Am J Physiol Heart Circ Physiol. 2005;289:H2291-2301. 
6. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat 
Rev Mol Cell Biol. 2002;3:475-486. 
7. Kuijper S, Turner CJ, Adams RH. Regulation of angiogenesis by Eph-ephrin 
interactions. Trends Cardiovasc Med. 2007;17:145-151. 
8. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 
2008;133:38-52. 
9. Merlos-Suarez A, Batlle E. Eph-ephrin signalling in adult tissues and cancer. Curr 
Opin Cell Biol. 2008;20:194-200. 
10. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. 
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 
2006;4:111-121. 
11. Konstantinova I, Nikolova G, Ohara-Imaizumi M, Meda P, Kucera T, Zarbalis K, 
Wurst W, Nagamatsu S, Lammert E. EphA-Ephrin-A-mediated beta cell 
communication regulates insulin secretion from pancreatic islets. Cell. 2007;129:359-
370. 
12. Ogawa K, Wada H, Okada N, Harada I, Nakajima T, Pasquale EB, Tsuyama S. 
EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of 
medullary tubule cells through Rho family GTPases. J Cell Sci. 2006;119:559-570. 
13. Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R. Loss of ephrin-A5 
function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci U S 
A. 2008;105:16620-16625. 
14. Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A. A critical role for the 
EphA3 receptor tyrosine kinase in heart development. Dev Biol. 2007;302:66-79. 
15. Twigg SR, Matsumoto K, Kidd AM, Goriely A, Taylor IB, Fisher RB, Hoogeboom 
AJ, Mathijssen IM, Lourenco MT, Morton JE, Sweeney E, Wilson LC, Brunner HG, 
Mulliken JB, Wall SA, Wilkie AO. The origin of EFNB1 mutations in 
craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the 
paucity of carrier males. Am J Hum Genet. 2006;78:999-1010. 
16. Davy A, Bush JO, Soriano P. Inhibition of gap junction communication at ectopic 
Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol. 
2006;4:e315. 
17. Lee HS, Nishanian TG, Mood K, Bong YS, Daar IO. EphrinB1 controls cell-cell 
junctions through the Par polarity complex. Nat Cell Biol. 2008;10:979-986. 
18. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO. Surface densities of 
ephrin-B1 determine EphB1-coupled activation of cell attachment through 
alphavbeta3 and alpha5beta1 integrins. Embo J. 1999;18:2165-2173. 
 16
19. Huynh-Do U, Vindis C, Liu H, Cerretti DP, McGrew JT, Enriquez M, Chen J, Daniel 
TO. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment 
and angiogenesis. J Cell Sci. 2002;115:3073-3081. 
20. Davy A, Aubin J, Soriano P. EphrinB1 forward and reverse signaling are required 
during mouse development. Genes Dev. 2004;18:572-583. 
21. Sanford JL, Edwards JD, Mays TA, Gong B, Merriam AP, Rafael-Fortney JA. 
Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in 
utrophin/dystrophin-deficient cardiomyopathic mice. J Mol Cell Cardiol. 
2005;38:323-332. 
22. Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, Jacobson JT, Yu C, Morley GE, 
Molkentin JD, Radice GL. Cardiac-specific loss of N-cadherin leads to alteration in 
connexins with conduction slowing and arrhythmogenesis. Circ Res. 2005;97:474-
481. 
23. Konieczny P, Fuchs P, Reipert S, Kunz WS, Zeold A, Fischer I, Paulin D, Schroder 
R, Wiche G. Myofiber integrity depends on desmin network targeting to Z-disks and 
costameres via distinct plectin isoforms. J Cell Biol. 2008;181:667-681. 
24. Wang X, Osinska H, Dorn GW, 2nd, Nieman M, Lorenz JN, Gerdes AM, Witt S, 
Kimball T, Gulick J, Robbins J. Mouse model of desmin-related cardiomyopathy. 
Circulation. 2001;103:2402-2407. 
25. Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, 
Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J. 
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy 
by pressure overload. J Mol Cell Cardiol. 2009;46:587-595. 
26. Danialou G, Comtois AS, Dudley R, Karpati G, Vincent G, Des Rosiers C, Petrof BJ. 
Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-
induced contractile failure and injury. Faseb J. 2001;15:1655-1657. 
27. Paulin D, Li Z. Desmin: a major intermediate filament protein essential for the 
structural integrity and function of muscle. Exp Cell Res. 2004;301:1-7. 
28. Ross RS, Borg TK. Integrins and the myocardium. Circ Res. 2001;88:1112-1119. 
29. Arvanitis D, Davy A. Eph/ephrin signaling: networks. Genes Dev. 2008;22:416-429. 
30. Gregory M, Dufresne J, Hermo L, Cyr D. Claudin-1 is not restricted to tight junctions 
in the rat epididymis. Endocrinology. 2001;142:854-863. 
31. Harris HJ, Davis C, Mullins JG, Hu K, Goodall M, Farquhar MJ, Mee CJ, McCaffrey 
K, Young S, Drummer H, Balfe P, McKeating JA. Claudin association with CD81 
defines hepatitis C virus entry. J Biol Chem;285:21092-21102. 
32. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon 
channels. Nat Rev Mol Cell Biol. 2003;4:285-294. 
33. Barresi R, Di Blasi C, Negri T, Brugnoni R, Vitali A, Felisari G, Salandi A, Daniel S, 
Cornelio F, Morandi L, Mora M. Disruption of heart sarcoglycan complex and severe 
cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet. 2000;37:102-
107. 
34. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, 
Capetanaki Y. The absence of desmin leads to cardiomyocyte hypertrophy and 
cardiac dilation with compromised systolic function. J Mol Cell Cardiol. 
1999;31:2063-2076. 
35. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, 
Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation 
of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted 
dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A. 
1997;94:13873-13878. 
 17
36. Shai SY, Harpf AE, Babbitt CJ, Jordan MC, Fishbein MC, Chen J, Omura M, Leil 
TA, Becker KD, Jiang M, Smith DJ, Cherry SR, Loftus JC, Ross RS. Cardiac 
myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and 
cardiac failure. Circ Res. 2002;90:458-464. 
37. Rasi K, Piuhola J, Czabanka M, Sormunen R, Ilves M, Leskinen H, Rysa J, Kerkela 
R, Janmey P, Heljasvaara R, Peuhkurinen K, Vuolteenaho O, Ruskoaho H, Vajkoczy 
P, Pihlajaniemi T, Eklund L. Collagen XV is necessary for modeling of the 
extracellular matrix and its deficiency predisposes to cardiomyopathy. Circ Res. 
2010;107:1241-1252. 
38. Aumailley M, Pesch M, Tunggal L, Gaill F, Fassler R. Altered synthesis of laminin 1 
and absence of basement membrane component deposition in (beta)1 integrin-
deficient embryoid bodies. J Cell Sci. 2000;113 Pt 2:259-268. 
39. Boulaksil M, Winckels SK, Engelen MA, Stein M, van Veen TA, Jansen JA, 
Linnenbank AC, Bierhuizen MF, Groenewegen WA, van Oosterhout MF, Kirkels JH, 
de Jonge N, Varro A, Vos MA, de Bakker JM, van Rijen HV. Heterogeneous 
Connexin43 distribution in heart failure is associated with dispersed conduction and 
enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail. 
40. Mays TA, Binkley PF, Lesinski A, Doshi AA, Quaile MP, Margulies KB, Janssen 
PM, Rafael-Fortney JA. Claudin-5 levels are reduced in human end-stage 
cardiomyopathy. J Mol Cell Cardiol. 2008;45:81-87. 
 
 
 18
Table 1. Morphometry and cardiac function of 2 month-old ephrin-B1 WT and KO mice, and of 
2 month-old  control and c KO mice. 
 
WT KO control c KO
Mice morphometry (n=13) (n=18) (n=6) (n=6)
BW (g) 30.5 ± 4.7 30.0 ± 3.9 25.5 ± 0.2 25.1 ± 0.6
HW (mg) 149 ± 2 152 ± 2 153 ± 4 146 ± 3
HW/BW (mg/g) 4.9 ± 1.0 5.0 ± 0.4 6.0 ± 0.2 5.9 ± 0.2
LW (mg) 188 ± 2 183 ± 2 151 ± 4 143 ± 3
LW/BW (mg/g) 6.2 ± 0.7 6.2 ± 1.2 5.9 ± 0.1 5.7 ± 0.1
Echocardiography (n=13) (n=18) (n=6) (n=6)
IVSTd (mm) 0.83 ± 0.06 0.85 ± 0.07 0.86 ± 0.02 0.80 ± 0,01*
DPWT (mm) 0.86 ± 0.07 0.84 ± 0.08 0.90 ± 0.02 0.80 ± 0,01**
LVEDD (mm) 3.01 ± 0.29 3.41 ± 0,38** 3.17 ± 0.05 3.48 ± 0,05**
LVESD (mm) 2.01 ± 0.25 2.25 ± 0.37 2.13 ± 0.06 2.28 ± 0.07
FS (%) 33.3 ± 3.9 34.4 ± 5.3 33.9 ± 1.2 34.2 ± 1.7
EF (%) 68.7 ± 5.5 69.7 ± 7.1 69.7 ± 1.3 70.0 ± 2.2
Electrocardiography (n=20) (n=17) (n=8) (n=9)
RRi (ms) 172 ± 4 191 ± 6*** 132 ± 2 144 ± 3*
PR (ms) 35.4 ± 1.3 39.4 ± 1,1*** 37.3 ± 0.5 42.4 ± 1,3*
QRS (ms) 11.7 ± 0.4 11.9 ± 0.8 12.4 ± 1.1 12.8 ± 0.6
QTc (ms) 51.6 ± 3.2 48.5 ± 2.1 51.0 ± 1.7 54.7 ± 2.3  
 
W, body weight; HW, heart weight, LW, lung weight; IVSTd, interventricular septum thickness in 
diastole; LVEDD, left ventricle end of diastole diameter; DPWT, diastolic posterior wall thickness; 
LVESD, left ventricle end-systole diameter; FS, fractional shortening; EF, ejection fraction, RRi, RR 
interval duration; PR, atrio-ventricular conduction time; QRS, complex duration; QTc, duration of QT 
corrected using Bazett formula. 
 
 
 19
 
FIGURE LEGENDS 
 
Figure 1. Localization of ephrin-B1 in the WT mouse heart. (A) Western blot analysis of ephrin-
B1 protein levels in cardiac tissue from 2-month old WT mice. Ephrin-B1 cannot be detected in 
ephrin-B1 KO mice. GAPDH expression was used as reference. (B) Immunofluorescence (IF) 
localization of ephrin-B1 in hearts from 2 month-old WT and KO mice at the plasma membrane of 
CMs (1), and micro-(2), macrovasculature (3). Specific ephrin-B1 staining is lost in KO mice. (C) IF 
co-localization of ephrin-B1 with CMs lateral membrane and with ECs as shown by Wheat-Germ-
Agglutinin (WGA) (C, upper) and Isolectin-B4 (I-B4) (C, lower) staining respectively in WT mice. 
Ephrin-B1 is absent from the intercalated disk (C, upper, inset). (D) Ephrin-B1 immunogold labeling 
confirmed its localization all along the CM lateral membrane (left) and in EC (right). bars: 20 µm (B 
and C), 5 µm (C, upper, inset), 1 µm (D). 
 
Figure 2. Progressive cardiac tissue architecture disarray and adult CM morphology alteration 
in ephrin-B1 KO mice. (A) H&E staining of cardiac tissue from 3-week and 2-month old mice 
showed cardiac tissue disarray in KO mice starting at 2 months of age. (B) WGA- IF staining 
highlighted loss of rod-shape morphology of CMs in KO mice at 2 months of age. (C) CMs area from 
2-month old mice were measured on WGA-stained heart sections and showed significant decrease of 
cross-sectional area of CMs from KO mice (n=3-5 per mice lineage group, 50-60 CMs per mouse). 
(D) CMs isolated from 2-month old KO mice displayed a long axis increase and short axis decrease. 
(n=2 mice per lineage group, 150-180 CMs per mouse). Scale bars: 50 µm (A and B), 15 µm (B, 
insets), 100 µm (D). 
 
Figure 3. Ephrin-B1 stabilizes the lateral membrane structure and stiffness of the CM through a 
claudin-5 dependant mechanism. (A) Electron microscopy shows high disorganization of the lateral 
membrane in CMs from KO mice. (B) (Upper panel) Representative single Indentation curve (plain 
line) from AFM studies performed on WT (blue, n=3 mice, 4 CMs per mouse, 470 total curves) or 
KO (red, n=3 mice, 4 CMs per mouse, 528 total curves) living CMs. In both cases, the Hertz model 
(dotted line) fitted quite well with experiment. (Lower panel) Distribution of the Young Modulus 
(Elasticity) was homogeneous in WT CMs whereas KO mice exhibited a high standard deviation 
(larger E distribution). (C) Immunofluorescence analysis revealed that ephrin-B1 KO mice lost 
claudin-5 and ZO-1 proteins localization at the lateral membrane of CMs while delocalizing in the ID 
and showed (D) specific downregulation of claudin-5 protein expression (n=6-7 per mice lineage 
group) and (E) gene expression (n=6 per mice lineage group; ns) as assessed by western-blot and 
qPCR analysis respectively. (F) Ephrin-B1 immunoprecipitation experiments (IP +) followed by 
western blot analysis on isolated CMs demonstrated the existence of complexes between ephrin-B1, 
claudin-5 and ZO-1 in WT mice as indicated. Note the lack of ephrin-B1, ZO-1 or claudin-5 
immunodetection in KO mice. (IP -), control IP experiments performed in the absence of ephrin-B1 
antibody. (G) BRET experiments in HEK-293T cells showed specific direct interaction between 
ephrin-B1 and claudin-5 compared with controls (Soluble GFP2 or α2A transmembrane receptor) 
(n=3). Scale bars: 1 µm (A), 50 µm (C), 25 µm (C, insets). 
 
Figure 4. Extracellular matrix defects in ephrin-B1 2-month old KO mice. (A) Electron 
micrographs of interstitial space between lateral membrane of two CMs from WT and KO mice. Note 
high basement membrane disarray (left, Arrowheads) and fibrillar collagens (right, Arrows) and 
nonfibrillar protein deposit (asterisks) disorganization in KO mice. (B) Comparative qPCR analysis 
revealed significant decrease of mRNA expression levels of proteins from basement membrane, 
interstitial ECM (fibrillar collagens), and ECM degradation system (matrix metalloproteinases 
(MMPs), tissue inhibitors of metalloproteinases (TIMPs)) in total RNA extracts from isolated CMs 
from KO mice. (n=6-10 per mice lineage group). Scale bars: 0.2 µm (A). 
 
Figure 5. Ephrin-B1 KO mice exhibited disorganized intercalated disk (ID) and sarcomeres. (A) 
Immunofluorescence localization of adherent junction (N-cadherin, upper,), desmosomes 
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(desmoplakin 1/2, middle) and gap junction (connexin 43, lower) in heart sections from 2-month old 
mice revealed an irregular dot-spot localization of the proteins along the ID in KO mice. (B) 
Distortion of ID ultrastructure could be observed in KO mice (inset highlights simplistic 
representation of ID morphology). (C) Immunofluorescence staining of myofilaments (Rhodamine-
phalloidin) or Z-lines (-actinin) in heart cryosections from 2-month old mice indicated myofibrils 
and Z-lines misalignment in KO mice correlating (D) with downregulation of α-actinin protein 
expression as shown by Western blot analysis in whole cardiac tissue extracts. No modification of 
total actin levels was detected (n=6-7 per mice lineage group). (E) Ultrastructure of sarcomeres 
showed loss of I band (WT, arrowheads), misalignment of both myofibrils and sarcomeres in KO 
mice. Scale bars: 30 µm (A), 5 µm (A, insets) 0.5 µm (B), 10 µm (C), 3 µm (C inset), 2 µm (E), 0.75 
µm (E inset). 
 
Figure 6. Ephrin-B1 is essential for the cardioprotective response elicited by pressure overload. 
Two-month old WT or ephrin-B1 KO mice were subjected to ascendant aortic banding (AAB). (A) 
Kaplan-Meier survival analysis of WT (n=27) and KO (n=23) mice. (B) CMs area were measured on 
WGA-stained heart sections and showed significant higher cross-sectional area in KO mice 30 days 
after AAB (Mean ± SEM, n=6-12 mice per lineage group; *** P < 0.001 versus sham control of the 
same genotype, ## P < 0.01, ### P < 0.001 versus WT of the same group, unpaired 2-tailed Student’s 
t test). (C) Echocardiographic measurements of ejection fraction (EF) or (D) LVEDD 30 days after 
AAB showed high hetererogenity in KO mice compared with WT with some mice developing heart 
failure (Mean and experimental points, n=23 WT, n=18 KO). (E) H&E staining of heart sections from 
WT or KO banded mice identified high disorganization of cardiac tissue architecture in KO mice. 
Note intersected and whorled CMs (left, middle) as well as CMs necrosis (right, dot-lines, 
arrowheads). Cell membranes WGA-staining of heart sections confirmed CMs disarray in the 
myocardium of KO mice. Endothelial cells I-B4 staining of heart sections also identified 
microcirculation disorganization with some capillaries crossing the myocardium in KO mice 
(arrowheads). (F) Cardiomyocyte efnb1 and claudin5 gene expression (qPCR) in WT mice submitted 
to transverse aortic banding (TAC) for 15 days (n=6) or in controls (n=5). (G) Linear regression 
analysis showing the existence of a relationship between CM efnb1 gene expression level (qPCR) and 
EF (echocardiography) in WT mice submitted or not to TAC. Scale bars: 100 µm (E). 
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Figure 1. Localization of ephrin-B1 in the WT mouse heart. (A) Western blot analysis of ephrin-B1 
protein levels in cardiac tissue from 2-month old WT mice. Ephrin-B1 cannot be detected in ephrin-B1 KO 
mice. GAPDH expression was used as reference. (B) Immunofluorescence (IF) localization of ephrin-B1 in 
hearts from 2 month-old WT and KO mice at the plasma membrane of CMs (1), and micro-(2), 
macrovasculature (3). Specific ephrin-B1 staining is lost in KO mice. (C) IF co-localization of ephrin-B1 
with CMs lateral membrane and with ECs as shown by Wheat-Germ-Agglutinin (WGA) (C, upper) and 
Isolectin-B4 (I-B4) (C, lower) staining respectively in WT mice. Ephrin-B1 is absent from the intercalated 
disk (C, upper, inset). (D) Ephrin-B1 immunogold labeling confirmed its localization all along the CM 
lateral membrane (left) and in EC (right). bars: 20 µm (B and C), 5 µm (C, upper, inset), 1 µm (D).
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Figure 2. Progressive cardiac tissue architecture disarray and adult CM morphology alteration in 
ephrin-B1 KO mice. (A) H&E staining of cardiac tissue from 3-week and 2-month old mice showed 
cardiac tissue disarray in KO mice starting at 2 months of age. (B) WGA- IF staining highlighted loss of 
rod-shape morphology of CMs in KO mice at 2 months of age. (C) CMs area from 2-month old mice were 
measured on WGA-stained heart sections and showed significant decrease of cross-sectional area of CMs
from KO mice (n=3-5 per mice lineage group, 50-60 CMs per mouse). (D) CMs isolated from 2-month old 
KO mice displayed a long axis increase and short axis decrease. (n=2 mice per lineage group, 150-180 CMs
per mouse). Scale bars: 50 µm (A and B), 15 µm (B, insets), 100 µm (D).
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Figure 3. Ephrin-B1 stabilizes the lateral membrane structure and stiffness of the CM through a 
claudin-5 dependant mechanism. (A) Electron microscopy shows high disorganization of the lateral 
membrane in CMs from KO mice. (B) (Upper panel) Representative single Indentation curve (plain line) 
from AFM studies performed on WT (blue, n=3 mice, 4 CMs per mouse, 470 total curves) or KO (red, n=3 
mice, 4 CMs per mouse, 528 total curves) living CMs. In both cases, the Hertz model (dotted line) fitted 
quite well with experiment. (Lower panel) Distribution of the Young Modulus (Elasticity) was 
homogeneous in WT CMs whereas KO mice exhibited a high standard deviation (larger E distribution). (C) 
Immunofluorescence analysis revealed that ephrin-B1 KO mice lost claudin-5 and ZO-1 proteins 
localization at the lateral membrane of CMs while delocalizing in the ID and showed (D) specific 
downregulation of claudin-5 protein expression (n=6-7 per mice lineage group) and (E) gene expression 
(n=6 per mice lineage group; ns) as assessed by western-blot and qPCR analysis respectively. (F) Ephrin-
B1 immunoprecipitation experiments (IP +) followed by western blot analysis on isolated CMs
demonstrated the existence of complexes between ephrin-B1, claudin-5 and ZO-1 in WT mice as indicated. 
Note the lack of ephrin-B1, ZO-1 or claudin-5 immunodetection in KO mice. (IP -), control IP experiments 
performed in the absence of ephrin-B1 antibody. (G) BRET experiments in HEK-293T cells showed 
specific direct interaction between ephrin-B1 and claudin-5 compared with controls (Soluble GFP2 or α2A 
transmembrane receptor) (n=3). Scale bars: 1 µm (A), 50 µm (C), 25 µm (C, insets).
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Figure 4. Extracellular matrix defects in 
ephrin-B1 2-month old KO mice. (A) Electron 
micrographs of interstitial space between lateral 
membrane of two CMs from WT and KO mice. 
Note high basement membrane disarray (left, 
Arrowheads) and fibrillar collagens (right, 
Arrows) and nonfibrillar protein deposit 
(asterisks) disorganization in KO mice. (B) 
Comparative qPCR analysis revealed significant 
decrease of mRNA expression levels of proteins 
from basement membrane, interstitial ECM 
(fibrillar collagens), and ECM degradation 
system (matrix metalloproteinases (MMPs), 
tissue inhibitors of metalloproteinases (TIMPs)) 
in total RNA extracts from isolated CMs from 
KO mice. (n=6-10 per mice lineage group). Scale 
bars: 0.2 µm (A).
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Figure 5. Ephrin-B1 KO mice exhibited disorganized intercalated disk (ID) and sarcomeres. (A) 
Immunofluorescence localization of adherent junction (N-cadherin, upper,), desmosomes (desmoplakin
1/2, middle) and gap junction (connexin 43, lower) in heart sections from 2-month old mice revealed an 
irregular dot-spot localization of the proteins along the ID in KO mice. (B) Distortion of ID 
ultrastructure could be observed in KO mice (inset highlights simplistic representation of ID 
morphology). (C) Immunofluorescence staining of myofilaments (Rhodamine-phalloidin) or Z-lines (α-
actinin) in heart cryosections from 2-month old mice indicated myofibrils and Z-lines misalignment in 
KO mice correlating (D) with downregulation of α-actinin protein expression as shown by Western blot 
analysis in whole cardiac tissue extracts. No modification of total actin levels was detected (n=6-7 per 
mice lineage group). (E) Ultrastructure of sarcomeres showed loss of I band (WT, arrowheads), 
misalignment of both myofibrils and sarcomeres in KO mice. Scale bars: 30 µm (A), 5 µm (A, insets) 
0.5 µm (B), 10 µm (C), 3 µm (C inset), 2 µm (E), 0.75 µm (E inset).
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Figure 6. Ephrin-B1 is essential for the cardioprotective response elicited by pressure overload. Two-
month old WT or ephrin-B1 KO mice were subjected to ascendant aortic banding (AAB). (A) Kaplan-
Meier survival analysis of WT (n=27) and KO (n=23) mice. (B) CMs area were measured on WGA-stained 
heart sections and showed significant higher cross-sectional area in KO mice 30 days after AAB (Mean ±
SEM, n=6-12 mice per lineage group; *** P < 0.001 versus sham control of the same genotype, ## P < 
0.01, ### P < 0.001 versus WT of the same group, unpaired 2-tailed Student’s t test). (C) 
Echocardiographic measurements of ejection fraction (EF) or (D) LVEDD 30 days after AAB showed high 
hetererogenity in KO mice compared with WT with some mice developing heart failure (Mean and 
experimental points, n=23 WT, n=18 KO). (E) H&E staining of heart sections from WT or KO banded 
mice identified high disorganization of cardiac tissue architecture in KO mice. Note intersected and whorled 
CMs (left, middle) as well as CMs necrosis (right, dot-lines, arrowheads). Cell membranes WGA-staining 
of heart sections confirmed CMs disarray in the myocardium of KO mice. Endothelial cells I-B4 staining of 
heart sections also identified microcirculation disorganization with some capillaries crossing the 
myocardium in KO mice (arrowheads). (F) Cardiomyocyte efnb1 and claudin5 gene expression (qPCR) in 
WT mice submitted to transverse aortic banding (TAC) for 15 days (n=6) or in controls (n=5). (G) Linear
regression analysis showing the existence of a relationship between CM efnb1 gene expression level
(qPCR) and EF (echocardiography) in WT mice submitted or not to TAC. Scale bars: 100 µm (E).
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Figure 7. A proposed model for ephrin-B1-mediated stabilization of the adult CM lateral membrane. 
(A) In normal adult CM, ephrin-B1 interacts with claudin-5/ZO-1 complex and stabilizes its localization at 
the lateral membrane and the interaction of the lateral membrane with the extracellular matrix, thus exerting 
mechanical tension and stretching both the ID and Z-lines (Red arrows). This interaction maintains ECM 
structural integrity. (B) In the absence of ephrin-B1, claudin-5 disappeared from the lateral membrane while 
ZO-1 delocalized to the ID and the lateral membrane loses anchorage at the ECM. This leads to 
morphological modifications of the CM characterized by a long axis increase and short axis decrease (Red 
arrows) which probably accounts for the increased stiffness of the lateral membrane. Altogether, these 
lateral membrane alterations indirectly impact on ID, Z-lines, basement membrane and interstitial matrix 
constitution / organization.
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Detailed Methods  
 
Animals. Efnb1 WT and KO mice were kept in a mixed S129/S4 × C57BL/6 genetic 
background. As described previously 1, in this background, a fraction of hemizygous null 
males survive to adulthood. Studies were performed only on males from 3 weeks and 2 
months of age. All animal procedures were carried out in accordance with the NIH guidelines 
and were approved by Midi-Pyrénées animal care and use committee. 
 
Generation of cardiomycoyte-specific ephrin-B1 deficient mice. Mice expressing Cre 
recombinase driven by the αMHC promoter (pure C57BL/6 genetic background) were 
crossed with efnb1flox/flox mice (pure 129S4 genetic background) to create αMHC-Cre-
efnb1flox/flox mice (cKO) or littermate control non-Cre-expressing efnb1flox/flox mice (control) 
(mixed C57BL/6×S129/S4 background). Mice carrying a floxed Efnb1 allele were described 
previously1. Both αMHC-Cre and efnb1flox/flox mice were provided by M.D. Schneider 
(Imperial College London, UK) and A. Davy (Develpment biology center, Toulouse, France) 
respectively. All experiments using the conditional cardiomyocyte ephrin-B1 KO mice were 
carried out on males from 2 months of age. 
 
Immunoprecipitation and Western-Blotting. For protein analysis from total cardiac extracts, 
cardiac tissue samples were directly lysed in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM 
NaCl, 1% NP-40, 1% NaDoc, 0.1% SDS) in the presence of protease inhibitors cocktail 
(Roche). Immunoprecipitation studies were conducted as previously described 2 from CMs’ 
lysate. Protein concentration of extracts was determined by the Bradford method (Bio-Rad) 
and equal amounts of proteins were either immunoprecipitated (2 mg) with monoclonal 
antibody to ephrin-B1 (R&D) or subjected directly (50 µg) to SDS-PAGE and transferred to 
nitrocellulose membranes (Millipore). Proteins were detected with primary antibodies 
followed by Horse Radish Peroxydase-conjugated secondary antibodies to goat, mouse, or 
rabbit IgG (GE Healthcare) using enhanced chemoluminescence detection reagent (GE 
Healthcare). Proteins quantification was obtained by densitometric analysis using ImageQuant 
5.2 software and was normalized to that of GAPDH expression and expressed in arbitraries 
units (A.U.). 
 
Antibodies. Primary antibodies in this study were : Goat anti-ephrin-B1 (R&D) (It is of note 
that several commercially available anti-ephrin-B1 antibodies were tested for the ligand 
detection but only one provided specific staining of the protein as demonstrated by loss of 
immunodetection in KO mice and this was used for all immunodetection of ephrin-B1); 
mouse anti-α sarcomeric actinin (Sigma); mouse anti-connexin 43 (Millipore); rabbit anti-N-
cadherin (Epitomics); rabbit anti-desmoplakin 1/2 (ARP); mouse anti-β-sarcoglycan 
(Novacastra); mouse anti-α-dystroglycan (IIH6 clone, Millipore); mouse anti-β1D integrin 
(Millipore); mouse anti-ZO-1 (Zymed), rabbit anti-claudin 5 (Acris antibodies); goat anti-pan-
actin (SantaCruz); rabbit anti-desmin (Cell Signaling Biotechnology); rabbit anti-α tubulin 
(Epitomics); mouse anti-GAPDH (Abcam). Secondary antibodies, donkey anti-goat OG-488 
Alexa Fluor; goat anti-rabbit OG-488-Alexa Fluor, donkey anti-mouse OG-488 Alexa Fluor, 
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donkey anti-goat Cy3-Alexa Fluor and donkey anti-rat Cy3-Alexa Fluor were all obtained 
from Invitrogen.  
Cell membranes, endothelial cells, nucleus and actin filaments were respectively stained with 
OG488-conjugated Wheat-Germ-Agglutinin (WGA) (Invitrogen) or OG488-conjugated 
Griffonia simplicifolia isolectin (I-B4) (Invitrogen), TO-PRO-3-iodide (Invitrogen) or 
tetramethylrhodamine-phalloidine B isothiocyanate (Dako). 
 
Bioluminescence Resonance Energy Transfert (BRET). Plasmid encoding mouse ephrin-B1 
was a generous gift from Dr Alice Davy while mouse claudin-5 was cloned from total RNA 
extracted from mouse lymphatic endothelial SVEC4-10 cell line before subcloning in 
pcDNA3.1 vector. For BRET2 experiments, ephrin-B1 and claudin-5 were both fused to their 
C-terminal with Renillia Luciferase 8 (Luc8) as energy donor (ephrin-B1-Luc8) or GFP2 as 
energy acceptor (Cld5-GFP2) respectively. For BRET experiments, HEK293T cells were 
transiently transfected using PEI method with plasmids encoding ephrin-B1-Luc8 or Cld5-
GFP2. Control experiments were performed by transfecting plasmids encoding ephrin-B1-
Luc8 together with α2A-AR (α2A-AR-GFP2) 3 as another unrelated transmembrane receptor or 
soluble GFP2. BRET2 measurements were carried out using comparable total Luc8 
luminescence and GFP2 fluorescence in all transfection conditions and performed as 
previously described 3 using a TECAN INFINITE 500 reader. 
 
Immunohistochemistry and confocal imaging. For histological analysis, hearts were excised 
and immediately fixed in 10 % formalin, embedded in paraffin and sectioned at 5 µm for 
hematoxylin-eosin (H&E) staining. Quantification of cardiac interstitial fibrosis was 
performed from Masson trichrome -stained paraffin-embedded heart sections using 
Niselement software (Nikon). 
For immunofluorescence studies, heart tissue was embedded in OCT and frozen in liquid 
nitrogen. Frozen sections (5 µm) were fixed with ice-cold acetone followed by 
permeabilization with 0.1 % Triton X-100 in PBS, blocking (Protein Block, Dako) and 
incubation with primary antibodies in antibody dilution buffer (0.1 % BSA / 0.1 % Tween 20 
/ 0.5 % Triton X-100 in PBS). Targeted proteins were visualized with appropriate 
fluorescence-conjugated secondary antibodies in antibody dilution buffer. Images were 
acquired with an LSM 510 confocal laser scanning microscope equipped with an Axiovert 
200M inverted microscope (Carl Zeiss, Jena, Germany). Zo-1 fluorescence was quantified 
using Nis-Elements BR2.3 (Nikon) software. 
Fluorescent staining of cell membranes (WGA), endothelial cells (I-B4) or actin filaments 
(phalloidine) were performed on paraffin-embedded heart sections.  
 
Transmission Electron Microscopy (TEM). Heart samples were fixed with 2% 
glutaraldehyde in Sorensen’s buffer. Post-fixation was performed in 1% OsO4 in Sorensen’s 
buffer for 1 hr followed by dehydratation in ethanol and propylene oxide and embedding in 
epoxy resin (Epon 812). Ultrathin sections (70 nm) were mounted on 100 mesh collodion-
coated copper grids and counterstained with 3% uranyl acetate in 50% ethanol and 8.5% lead 
citrate before being examined on a HU12A Hitachi electron microscope at 75 KV.  
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For immunogold staining, tissues were first fixed in 0.1% glutaraldehyde / 2% formaldehyde 
in 0.1 M phosphate buffer (pH 7.4), washed with 3,5% sucrose and 0.5 M ammonium 
chloride in 0.1M phosphate buffer. They were finally washed in 0.05 M maleate buffer and 
prestained with 2% uranyl acetate aqueous solution. Samples were washed with maleate 
buffer followed by dehydratation in ethanol gradients and then embedded in HM20 resin. 
After 48 hours of UV-polymerisation, ultrathin sections (70 nm) were mounted on 150 mesh 
collodion-coated gold grids. Grids were then saturated PBS / 5% BSA and incubated in the 
presence of anti-ephrin-B1 antibody followed by incubation with secondary gold-labelled 
anti-goat antibody (10 nm nanogold particles). Grids were finally counterstained with 3% 
uranyl acetate in 50% ethanol before being examined on a HU12A Hitachi electron 
microscope at 75 KV.  
 
Cardiomyocytes isolation. For gene expression quantification, ventricular adult CMs were 
isolated from adult 2 month-old mice using the Langendorff perfusion method as previously 
described 4. Briefly, hearts were quickly removed from the chest after euthanasia and the aorta 
retroperfused with a Ca2+-free bicarbonate-based buffer containing 1mg/ml collagenase 
(Worthington type II). Following enzymatic digestion, dispersed myocytes were filtered 
through a 150 μm mesh and gently centrifuged at 500 rpm for 30 seconds. After rinsing, cells 
were frozen and further used for RNA purification. For Atomic Force Microscopy, 
immediately after isolation, CMs were plated 20 min on Laminin (Invitrogen) coated plates in 
CM culture medium (MEM, 5% Fetal Calf Serum, 100 U.mL-1 Penicilin, 2 mM.L-1 Glutamin) 
supplemented with 10 mM 2,3-butanedione monoxime (BDM) to inhibit cell contraction. 
 
Measurement of cardiac myocytes surface area and microvascular capillary density. In 
cardiac tissue, CMs area and capillary density were measured using WGA- or I-B4-stained 
heart sections respectively. CMs area and capillary density were measured in cross-sectional 
tissue orientation by manually tracing the cell contour or counting capillaries number 
respectively on images acquired on Zeiss Observer Z.1 microscope (Carl Zeiss, Jena, 
Germany) at ×400 (CMs) or ×100 (ECs) magnification and using Axio Vision Rel 4.7 
software (Carl Zeiss). For measurements of long and short axis of isolated CMs, cells were 
plated on Laminin (Invitrogen) coated plates for 15min at 37° C immediately after isolation. 
Phase-contrast images were acquired on Zeiss Observer Z.1 microscope. Cell size was 
estimated at the focal plane in which the largest surface was detected. CMs longer and shorter 
axes were measured using Axio Vision Rel 4.7 software at x100 magnification.  
 
Total RNA isolation and real-time quantitative RT-PCR. Extraction of RNA from cardiac 
ventricles or isolated adult CMs was performed using Qiagen RNeasy Fibrous Tissue Mini 
Kit or Qiagen RNeasy Tissue Mini Kit (QIAGEN) respectively. First-strand cDNA was 
synthesized using the superscript II RT-PCR system (Invitrogen) with random hexamers. 
Negative controls without reverse transcriptase were made to verify the absence of genomic 
DNA contamination. Real-time PCR was performed in an ABI 7500 Fast (Applied 
Biosystems,) in 96-well plates. Twenty-five microliters of cDNA from RT reaction was then 
mixed with specific primers and EVA green mix (Euromedex). A panel of 5 housekeeping 
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genes (GAPDH, HPRT, 18S, β2myoglobulin, and PPIA) were tested for their expression 
stability 5, and geometric mean value of the three housekeeping genes most stably expressed 
across the samples was used for normalization (GAPDH, HPRT, PPIA). Relative gene 
expression was calculated by the comparative Ct method 6. 
 
Atomic Force Microscopy (AFM). Atomic Force Microscopy experiments were conducted in  
CM culture medium, at 37 °C under 5% CO2 flow, using the perfusing cell from the Bioscope 
Catalyst (Bruker, Santa Barbara, CA, USA). We used bare MLCT AFM probes which present 
a pyramidal tip, with a curvature radius of 35°, made of Si3N4, manufactured by Bruker. The 
cantilever spring constants were systematically measured using the thermal tune method 7 and 
has been found to range from 10 to 30 pN/nm. The maximal force applied to the cell has been 
limited to 2 nN in order to probe the cell wall elasticity (Young Modulus) and not the cell 
turgor pressure as made at higher loading forces 8, 9 The force (F) versus displacement curves 
were converted into indentation (δ) curves using a homemade software and fitted to the Hertz 
model 10 (equation 1) taking into account a conical tip with an opening angle of 35° (α). 
Finally, the Poisson ratio (ν) has been arbitrary fixed to 0.5.  
 
2
2 δ)ν1(
αtan2
−= π
EF  (1) 
 
Force curves were recorded on the centre of living cells, on a single point or according to a 
matrix of 16x16 points on areas of 10 µm². For each force curve the Young Modulus (E) is 
calculated and the repartition of E plotted on histograms. 
 
Echocardiography. Animals were anesthetized by intraperitoneal injection of 10 µg/g 
etomidate and underwent noninvasive transthoracic echocardiography using a General 
Electric Vivid 7® (GE Medical System) equipped with a 14-MHz linear probe. Cardiac 
ventricular dimensions were measured in M-mode images at least 5 times for each animal. FS 
was calculated as (LVEDD-LVESD)/LVEDD and expressed as percentage. LV ejection 
fraction (EF) was calculated using Teichholz formula. Measurements were obtained by an 
examiner blinded to the genotype of the animals. 
 
Surface ECG recording. A 10 min ECG was obtained under light and 1.5 % isoflurane 
anaesthesia using three limb leads and digitalized at 4000 Hz. Data were analysed on series of 
at least 150 consecutive QRS complexes using LabChart Pro (v 6.1.1) software (AD 
Instruments).  
 
Ascendant Aortic Banding (AAB). Two-month old mice were anesthesized with 4 % 
isoflurane, ventilated and the left thorax was opened at the second intercostals space. Aortic 
constriction was performed by legating the ascending aorta using a 7-0 Prolene suture under a 
dissecting microscope. For this purpose, two nots of a 1.5 mm distance (26-gauge needle 
circumference), were made on the thread which was carefully introduced around the 
ascending aorta. Both nots were tight together to perform aortic constriction. Age-matched 
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animals underwent identical surgical procedure except for ligation of the aorta (sham-operated 
mice). 
 
Trans Aortic Banding (TAC). Transverse thoracic aortic constriction (TAC) was performed 
on six-week-old male C57BL/6J mice. Briefly, mice were anesthetized with isofluorane, the 
chest opened through a small thoracic window and a 27 G needle placed on the transverse 
aorta. The band was secured using a prolene suture, the needle was then removed and the 
chest closed. Fifteen days post-surgery, echocardiography was performed and mice were 
sacrificed for further cardiomyocytes purification and RNA extraction. Both the surgeon and 
echocardiographer were blinded to animal genotype. 
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SUPPLEMENTAL FIGURES LEGENDS 
 
Online Figure I. Ephrin-B1 expression during postnatal period of the CM. (A) Ephrin-
B1, Topro-3 (nucleus) and WGA (cell membranes) immunofluorescence co-staining in rat 
heart cryosections revealed that ephrin-B1 was expressed in CMs at neonatal stage (P0) but 
only localized in their nuclei (upper panels). Localization of ephrin-B1 at the lateral 
membrane appeared more lately at the end of the maturation step (P20) (middle, lower 
panels). (B) At neonatal stage, immunofluorescence co-staining revealed that ephrin-B1 was 
already expressed in endothelial cells (I-B4) (arrow heads). Scale bars: 20 µm (A and B). 
 
Online Figure II. Histological analysis of cardiac tissue from 2-month old ephrin-B1 WT 
and KO mice. (A) No differences in fibrosis or (B) capillary density between 2-month old 
WT and KO hearts as measured by trichrome or I-B4-stained heart sections respectively. 
(Mean ± SEM, n=5-7 per mice lineage group, ns, non significant, unpaired 2-tailed Student’s t 
test).  
 
Online Figure III.  Characterization of α-MHC-Cre+/--Efnb1flox/flox mouse (Conditional 
KO, cKO). (A) Exons 2-5 from Ephrin-B1 encoding gene (efnb1) are flanked by 2 loxP sites. 
The primers bind before and after the 3’ LoxP. (B) A PCR analysis on genomic DNA from 
tail and isolated cardiomyocytes was performed on 2 month-old α-MHC-Cre+/-efnb1flox/flox 
(cKO) and α-MHC-Cre-/-efnb1flox/flox (Control) mice. Upper and middle panels show the -
MHC-Cre and LoxP (Efnb1 forward primer n°2/efnb1 reverse primer) amplification into the 
genome while the lower panel shows specific deletion of efnb1 in ventricular isoled CMs and 
not from the tail of the same animal as indicated by the detection of the 2 LoxP amplicon in 
CMs only (Efnb1 forward primer n°1/efnb1 reverse primer). (C) Western-blot analysis of 
ephrin-B1 protein expression in isolated CMs from 2-month old control and cKO mice. 
Ephrin-B1 cannot be detected in CMs from ephrin-B1 cKO mice. (D) Immunofluorescence 
localization of ephrin-B1 in hearts from 2 month-old Control and cKO mice shows a specific 
deletion of this protein at the lateral membrane of CMs (arrows) from cKO mice while ephrin-
B1 expression in endothelial cells (asterisks) is preserved. Scales bars: 20µm (D). 
 
Online figure IV. Cardiac characterization of 2 month-old efnb1 cKO mice. A) Electron 
microscopy shows high disorganization of the lateral membrane in CMs from cKO mice. (B) 
and (C) Immunofluorescence analysis revealed that efnb1 cKO mice lost claudin-5 and ZO-1 
proteins localization at the lateral membrane of CMs specifically (arrows). Note that specific 
claudin-5 expression in endothelial cells (asterisks) is preserved in cKO mice (D) Electron 
micrographs of interstitial space between lateral membrane of two CMs from control and cKO 
mice. Note high disorganization of fibrillar collagens (arrows) in cKO mice. (E) 
Ultrastructure of sarcomeres show loss of I band (control, arrows), and misalignment of both 
myofibrils and sarcomeres in  cKO mice. Scales bars: 20µm (A) 50µm (B), 0.75µm (C and 
E), 0.2µm (D). 
 
Online Figure V. Expression and localization analysis of cell-matrix jonctions of the 
CMs lateral membrane from 2-month old ephrin-B1 WT and KO mice. (A) No 
modification of localization or (B) expression of cell-matrix β1-integrin, β-sarcoglycan and α-
dystroglycan proteins in KO mice as assessed by immunofluorescence or Western blot studies 
respectively (Mean ± SEM, n=4-8 per mice lineage group, ns, non significant, unpaired 2-
tailed Student’s t test). (C) Claudin-5 localized specifically at the lateral membrane of CMs 
from rat hearts as shown by immunofluorescence WGA co-staining. (D) ZO-1 localized at 
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both the lateral membrane and the intercalated disk of isolated CMs as shown by 
immunofluorescence WGA co-staining. Scale bars: 20 µm (A and C), 10 µm (D). 
 
Online Figure VI. Cell-matrix system expression in total cardiac tissue from 2-month 
old ephrin-B1 WT and KO mice. Comparative qRT-PCR analysis revealed no difference of 
mRNA expression levels of proteins from interstitial ECM (fibrillar collagens) and ECM 
degradation system (matrix metalloproteinases (MMPs), tissue inhibitors of 
metalloproteinases (TIMPs)) in total RNA cardiac tissue extracts from 2-month old WT and 
KO mice. (Mean ± SEM, n=6-10 per mice lineage group, ns, non significant, unpaired 2-
tailed Student’s t test). 
 
Online Figure VII. Quantitative analysis of intercalated disk (ID) proteins expression 
and ID space in 2-month old ephrin-B1 WT and KO mice. No modification of N-cadherin 
(A), desmoplakin 1/2 (B) and connexin 43 (C) proteins expression between WT and KO mice 
as assessed by Western blot analysis of whole cardiac tissue extracts (Mean ± SEM, n=4-5 
mice per mice lineage group, ns, non significant, unpaired 2-tailed Student’s t test). (D) 
Measurement of ID space using electron micrographs did not reveal modifications between 
WT and KO mice. (Mean ± SEM, n=3 mice per lineage group, ns, non significant, unpaired 2-
tailed Student’s t test). 
 
Online Figure VIII. Quantitative analysis of sarcomere associated myofilaments 
expression and sarcomere ultrastructure in 2-month old ephrin-B1 WT and KO mice. 
Immunofluorescence staining of desmin (A) and α-tubulin (C) in heart cryosections and (B 
and D) western blot analysis on cardiac extracts from ephrin-B1 WT and KO mice did not 
reveal modifications of these proteins localization or expression in KO hearts. (Mean ± SEM, 
n=4 mice per lineage group, ns, non significant, unpaired 2-tailed Student’s t test). (E, F, G) 
Quantitative analysis of sarcomere ultrastructure in electron micrographs from WT and KO 
hearts indicated that KO mice showed a significant decrease of sarcomeres length (E), 
increase in sarcomeres width (F) and high heterogeneity in Z-lines height (G). (Mean ± SEM, 
n=3 mice per lineage group, 100 independent measurements per mouse; *** P< 0.001, 
unpaired 2-tailed Student’s t test). Scale bars: 5 µm (A), 15 µm (C). 
 
Online Figure IX.  Histomorphological and genetic profile of cardiac tissue of 2-month 
old ephrin-B1 WT and KO mice subjected to ascendant aortic banding (AAB). (A) IVST 
(left) and DPWT (right) echocardiographic measurements before and 30 days after AAB 
showed higher hypertrophic response in KO mice (n=20 WT, n=17 KO). (B) WT and KO 
mice exhibited similar induction of fetal gene program 30 days following AAB (Mean ± 
SEM, n=7-10 per mice lineage group, ***P < 0.001 versus sham control of the same 
genotype, ns, non significant versus WT of the same group, One-way ANOVA, Tukey test). 
(C) WT and KO mice developed comparable fibrosis as quantified by trichrome-Masson-
stained heart sections (Mean ± SEM, n=6-12 mice per lineage group, *P < 0.05 versus sham 
control of the same genotype, ns, non significant versus WT of the same group, unpaired 2-
tailed Student’s t test), in agreement with (D) similar induction of fibrotic genes (Mean ± 
SEM, n=7-10 mice per lineage group, * P < 0.05, ***P < 0.001 versus sham control of the 
same genotype, ns, non significant versus WT of the same group, One-way ANOVA, Tukey 
test). (E) Cardiac pressure overload did not modify capillaries density in ephrin-B1 KO mice. 
Quantification of capillaries density using I-B4 staining heart sections did not reveal 
modifications between KO and WT mice 30 days after AAB. (Mean ± SEM, n= 6-12 mice 
per lineage group, ns, non significant versus WT of the same group). 
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Online Table 1. Variations of echocardiographic parameters in 2 
month-old ephrin-B1 WT and KO mice induced by 30 days aortic 
ascendant banding (AAB). 
WT (n=20) KO (n=17)
IVST (mm) 0.38 ± 0.17 0.53 ± 0.22*
DPWT (mm) 0.34 ± 0.15 0.49 ± 0.28*
LVEDD (mm) -0.04 ± 0.39 -0.03 ± 0.69
LVESD (mm) 0.37 ± 0.22 0.58 ± 0.21**
FS (%) 4.6 ± 9.8 4.2 ± 15.8
EF (%) 2.7 ± 9.7 1.0 ± 16.3  
IVST, Interventricular septum thickness in diastole; DPWT, diastolic 
posterior wall thickness; LVEDD, left ventricle end-diastole diameter; 
LVESD, left ventricle end-systole diameter; FS, fractional shortening; 
EF, ejection fraction. Results are represented as the difference of the 
parameters measured 30 days after AAB and before AAB. Results are 
expressed as mean ± SD. P values were determined using unpaired 2-
tailed Student’s t test. * P  < 0.05, ** P  < 0.01. 
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Online Table 2. Basal echocardiographic parameters in 2 month-old ephrin-B1 WT and KO mice 
before aortic ascendant banding. 
 
WT KO
Sham (n=7) Banded (n=27) Sham (n=6) Banded (n=18) F P
IVST (mm) 0.88 ± 0.11 0.91 ± 0.11 0.89 ± 0.06 0.84 ± 0.08 2.12 0.239
DPWT (mm) 0.92 ± 0.13 0.93 ± 0.10 0.97 ± 0.11 0.86 ± 0.08 2.66 0.447
LVEDD (mm) 2.93 ± 0.25 2.87 ± 0.30 3.35 ± 0.33 3.21 ± 0.37° 5.74 0.0019
LVESD (mm) 2.01 ± 0.31 1.77 ± 0.34 1.95 ± 0.42 2.02 ± 0.39 2.11 0.1093
FS (%) 33.7 ± 4.4 37.6 ± 6.4 38.9 ± 4.7 36.7 ± 5.6 1.11 0.3516
EF (%) 69.1 ± 5.3 73.9 ± 7.2 75.8 ± 5.6 72.7 ± 7.4 1.68 0.738
HR (bpm) 524 ± 25 520 ± 57 464 ± 68 462 ± 55°° 4.79 0.0053  
IVST, Interventricular septum thickness; DPWT, diastolic posterior wall thickness; LVEDD, left ventricle 
end-diastole diameter; LVESD, left ventricle end-systole diameter; FS, fractional shortening; EF, ejection 
fraction; HR, heart rate. Results are expressed as mean ± SD. F values were assessed using one-way 
ANOVA followed by Bonferroni post-hoc test. ° P  < 0.05, °° P  < 0.01 when compared to the corresponding 
value of the WT lineage group. 
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Online Table 3. Morphometry and cardiac function of 2 month-old ephrin-B1 WT and KO mice 30 days 
after aortic ascendant banding. 
 
WT KO
Sham (n=7) Banded (n=27) Sham (n=6) Banded (n=18) F P
IVST (mm) 0.91 ± 0.07 1.29 ± 0.19*** 0.90 ± 0.03 1.38 ± 0.21°°° 19.07 <0.0001
DPWT (mm) 0.98 ± 0.11 1.27 ± 0.17** 0.86 ± 0.18 1.35 ± 0.30** 11.16 <0.0001
LVEDD (mm) 2.99 ± 0.23 2.77 ± 0.37 3.42 ± 0.52° 3.26 ± 0.77° 4.24 <0.0094
LVESD (mm) 1.98 ± 0.29 1.66 ± 0.42 2.19 ± 0.53 1.97 ± 0.92 1.75 0.1669
FS (%) 33.7 ± 5.2 42.2 ± 11.9 35.2 ± 4.3 41.0 ± 15.4 1.26 0.2964
EF (%) 69.1 ± 7.2 79.3 ± 8.4 71.0 ± 5.7 73.7 ± 15.9 2.16 0.1040
HR (bpm) 504 ± 47 514 ± 58 449 ± 40° 464 ± 80° 3.00 0.0388
BW (g) 31.7 ± 2.4 30.6 ± 1.8 30.9 ± 2.8 27.5 ± 3.0° 4.46 0.0081
HW (mg) 153 ± 24 183 ± 27 148 ± 25 190 ± 17 3.49 0.0235
HW/BW (mg/g) 5.0 ± 0.9 5.8 ± 0.9 4.8 ± 0.4 6.9 ± 1.9* 6.67 0.0010
LW (mg) 186 ± 22 206 ± 27 187 ± 29 189 ± 34 0.96 0.4220
LW/BW (mg/g) 6.1 ± 0.8 6.5 ± 0.3 6.1 ± 1.0 6.9 ± 1.1 1.06 0.3733  
IVST, Interventricular septum thickness; DPWT, diastolic posterior wall thickness; LVEDD, left ventricle end-
diastole diameter; LVESD, left ventricle end-systole diameter; FS, fractional shortening; EF, ejection fraction; 
HR, heart rate; BW, body weight; HW, heart weight; LW, lung weight. Results are expressed as mean ± SD. F 
values were assessed using one-way ANOVA followed by Bonferroni post-hoc test. * P < 0.05, ** P < 0.01, 
*** P < 0.001 when compared to the sham value of the same lineage group; ° P < 0.05, °°° P  < 0.001 when 
compared to the corresponding value of the WT lineage group. 
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Online Figure I. Ephrin-B1 expression during postnatal period of the CM. (A) Ephrin-B1, Topro-3 
(nucleus) and WGA (cell membranes) immunofluorescence co-staining in rat heart cryosections revealed 
that ephrin-B1 was expressed in CMs at neonatal stage (P0) but only localized in their nuclei (upper 
panels). Localization of ephrin-B1 at the lateral membrane appeared more lately at the end of the maturation 
step (P20) (middle, lower panels). (B) At neonatal stage, immunofluorescence co-staining revealed that 
ephrin-B1 was already expressed in endothelial cells (I-B4) (arrow heads). Scale bars: 20 µm (A and B).
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Online Figure II
Online Figure II. Histological analysis of 
cardiac tissue from 2-month old ephrin-B1 
WT and KO mice. (A) No differences in fibrosis 
or (B) capillary density between 2-month old WT 
and KO hearts as measured by trichrome or I-B4-
stained heart sections respectively. (Mean ±
SEM, n=5-7 per mice lineage group, ns, non 
significant, unpaired 2-tailed Student’s t test).
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Online Figure III.  Characterization of α-MHC-Cre+/--Efnb1flox/flox mouse (Conditional KO, cKO). (A) 
Exons 2-5 from Ephrin-B1 encoding gene (efnb1) are flanked by 2 loxP sites. The primers bind before and 
after the 3’ LoxP. (B) A PCR analysis on genomic DNA from tail and isolated cardiomyocytes was
performed on 2 month-old α-MHC-Cre+/-efnb1flox/flox (cKO) and α-MHC-Cre-/-efnb1flox/flox (Control) mice. 
Upper and middle panels show the α-MHC-Cre and LoxP (Efnb1 forward primer n°2/efnb1 reverse 
primer) amplification into the genome while the lower panel shows specific deletion of efnb1 in ventricular
isoled CMs and not from the tail of the same animal as indicated by the detection of the 2 LoxP amplicon in 
CMs only (Efnb1 forward primer n°1/efnb1 reverse primer). (C) Western-blot analysis of ephrin-B1 protein 
expression in isolated CMs from 2-month old control and cKO mice. Ephrin-B1 cannot be detected in CMs
from ephrin-B1 cKO mice. (D) Immunofluorescence localization of ephrin-B1 in hearts from 2 month-old 
Control and cKO mice shows a specific deletion of this protein at the lateral membrane of CMs (arrows)
from cKO mice while ephrin-B1 expression in endothelial cells (asterisks) is preserved. Scales bars: 20µm 
(D).
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Online figure IV. Cardiac characterization of 2 month-old efnb1 cKO mice. A) Electron microscopy 
shows high disorganization of the lateral membrane in CMs from cKO mice. (B) and (C) 
Immunofluorescence analysis revealed that efnb1 cKO mice lost claudin-5 and ZO-1 proteins localization at 
the lateral membrane of CMs specifically (arrows). Note that specific claudin-5 expression in endothelial 
cells (asterisks) is preserved in cKO mice (D) Electron micrographs of interstitial space between lateral 
membrane of two CMs from control and cKO mice. Note high disorganization of fibrillar collagens 
(arrows) in cKO mice. (E) Ultrastructure of sarcomeres show loss of I band (control, arrows), and 
misalignment of both myofibrils and sarcomeres in  cKO mice. Scales bars: 20µm (A) 50µm (B), 0.75µm 
(C and E), 0.2µm (D).
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Online Figure V
Online Figure V. Expression and localization analysis of cell-matrix jonctions of the CMs lateral 
membrane from 2-month old ephrin-B1 WT and KO mice. (A) No modification of localization or (B) 
expression of cell-matrix β1-integrin, β-sarcoglycan and α-dystroglycan proteins in KO mice as assessed by 
immunofluorescence or Western blot studies respectively (Mean ± SEM, n=4-8 per mice lineage group, ns, 
non significant, unpaired 2-tailed Student’s t test). (C) Claudin-5 localized specifically at the lateral 
membrane of CMs from rat hearts as shown by immunofluorescence WGA co-staining. (D) ZO-1 localized 
at both the lateral membrane and the intercalated disk of isolated CMs as shown by immunofluorescence
WGA co-staining. Scale bars: 20 µm (A and C), 10 µm (D).
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Online Figure VI
Online Figure VI. Cell-matrix system expression in total cardiac tissue from 2-month old ephrin-B1 
WT and KO mice. Comparative qRT-PCR analysis revealed no difference of mRNA expression levels of
proteins from interstitial ECM (fibrillar collagens) and ECM degradation system (matrix metalloproteinases
(MMPs), tissue inhibitors of metalloproteinases (TIMPs)) in total RNA cardiac tissue extracts from 2-month 
old WT and KO mice. (Mean ± SEM, n=6-10 per mice lineage group, ns, non significant, unpaired 2-tailed 
Student’s t test).
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Online Figure VII. Quantitative analysis of intercalated disk (ID) proteins expression and ID space in 
2-month old ephrin-B1 WT and KO mice. No modification of N-cadherin (A), desmoplakin 1/2 (B) and 
connexin 43 (C) proteins expression between WT and KO mice as assessed by Western blot analysis of 
whole cardiac tissue extracts (Mean ± SEM, n=4-5 mice per mice lineage group, ns, non significant, 
unpaired 2-tailed Student’s t test). (D) Measurement of ID space using electron micrographs did not reveal 
modifications between WT and KO mice. (Mean ± SEM, n=3 mice per lineage group, ns, non significant, 
unpaired 2-tailed Student’s t test).
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Online Figure VIII. Quantitative analysis of sarcomere associated myofilaments expression and 
sarcomere ultrastructure in 2-month old ephrin-B1 WT and KO mice. Immunofluorescence staining of 
desmin (A) and α-tubulin (C) in heart cryosections and (B and D) western blot analysis on cardiac extracts 
from ephrin-B1 WT and KO mice did not reveal modifications of these proteins localization or expression 
in KO hearts. (Mean ± SEM, n=4 mice per lineage group, ns, non significant, unpaired 2-tailed Student’s t
test). (E, F, G) Quantitative analysis of sarcomere ultrastructure in electron micrographs from WT and KO 
hearts indicated that KO mice showed a significant decrease of sarcomeres length (E), increase in 
sarcomeres width (F) and high heterogeneity in Z-lines height (G). (Mean ± SEM, n=3 mice per lineage 
group, 100 independent measurements per mouse; *** P< 0.001, unpaired 2-tailed Student’s t test). Scale 
bars: 5 µm (A), 15 µm (C).
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Online Figure IX
Online Figure IX.  Histomorphological and genetic profile of cardiac tissue of 2-month old ephrin-B1 
WT and KO mice subjected to ascendant aortic banding (AAB). (A) IVST (left) and DPWT (right) 
echocardiographic measurements before and 30 days after AAB showed higher hypertrophic response in 
KO mice (n=20 WT, n=17 KO). (B) WT and KO mice exhibited similar induction of fetal gene program 30 
days following AAB (Mean ± SEM, n=7-10 per mice lineage group, ***P < 0.001 versus sham control of 
the same genotype, ns, non significant versus WT of the same group, One-way ANOVA, Tukey test). (C) 
WT and KO mice developed comparable fibrosis as quantified by trichrome-Masson-stained heart sections 
(Mean ± SEM, n=6-12 mice per lineage group, *P < 0.05 versus sham control of the same genotype, ns, 
non significant versus WT of the same group, unpaired 2-tailed Student’s t test), in agreement with (D) 
similar induction of fibrotic genes (Mean ± SEM, n=7-10 mice per lineage group, * P < 0.05, ***P < 0.001 
versus sham control of the same genotype, ns, non significant versus WT of the same group, One-way 
ANOVA, Tukey test). (E) Cardiac pressure overload did not modify capillaries density in ephrin-B1 KO 
mice. Quantification of capillaries density using I-B4 staining heart sections did not reveal modifications 
between KO and WT mice 30 days after AAB. (Mean ± SEM, n= 6-12 mice per lineage group, ns, non 
significant versus WT of the same group).
Genet et al.
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